Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness
Author:
Singh Pragya1, Ramanathan Varshini2ORCID, Zhang Yang2ORCID, Georgakoudi Irene12, Jay Daniel G.1
Affiliation:
1. Department of Developmental, Molecular and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111, USA 2. Department of Biomedical Engineering, Tufts University School of Engineering, Medford, MA 02155, USA
Abstract
Cancer cell-secreted eHsp90 binds and activates proteins in the tumor microenvironment crucial in cancer invasion. Therefore, targeting eHsp90 could inhibit invasion, preventing metastasis—the leading cause of cancer-related mortality. Previous eHsp90 studies have solely focused on its role in cancer invasion through the 2D basement membrane (BM), a form of extracellular matrix (ECM) that lines the epithelial compartment. However, its role in cancer invasion through the 3D Interstitial Matrix (IM), an ECM beyond the BM, remains unexplored. Using a Collagen-1 binding assay and second harmonic generation (SHG) imaging, we demonstrate that eHsp90 directly binds and aligns Collagen-1 fibers, the primary component of IM. Furthermore, we show that eHsp90 enhances Collagen-1 invasion of breast cancer cells in the Transwell assay. Using Hsp90 conformation mutants and inhibitors, we established that the Hsp90 dimer binds to Collagen-1 via its N-domain. We also demonstrated that while Collagen-1 binding and alignment are not influenced by Hsp90’s ATPase activity attributed to the N-domain, its open conformation is crucial for increasing Collagen-1 alignment and promoting breast cancer cell invasion. These findings unveil a novel role for eHsp90 in invasion through the IM and offer valuable mechanistic insights into potential therapeutic approaches for inhibiting Hsp90 to suppress invasion and metastasis.
Funder
NIH Research Grant program National Institute of Biomedical Imaging and Bioengineering National Institute of Health, the Office of the Director National Cancer Institute
Subject
Cancer Research,Oncology
Reference98 articles.
1. Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., and Lewis, D.R. (2023, April 01). SEER Cancer Statistics Review (CSR) 1975–2018, Available online: https://seer.cancer.gov/csr/1975_2018/. 2. Macdonald, S., Oncology, R., and General, M. (2022). Breast Cancer Facts & Figures 2022–2024. Am. Cancer Soc. 3. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness;Eustace;Nat. Cell Biol.,2004 4. Devarakonda, C.V., Kita, D., Phoenix, K.N., and Claffey, K.P. (2015). Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer, 15. 5. High HSP90 expression is associated with decreased survival in breast cancer;Pick;Cancer Res.,2007
|
|